Edwin Diaz. Jose Altuve. Rhys Hoskins. Gavin Lux. Brendan Rodgers. All are injured and out for significant portions of the 2023 season (in the cases of Diaz, Hoskins and Lux, it looks like the entire season), so their respective teams would be wise to test the trade market for replacement help. Meanwhile, the Yankees’ rotation has been decimated, at least temporarily. Luis Severino, Carlos Rodon, and Frankie Montas are all on the IL. Clarke Schmidt has gone from likely bullpen arm to...

Despite the fact that it’s still early in the season, we’re already hearing rumblings in the media about Max Scherzer becoming a trade candidate at the deadline. After all, the Nationals’ chances of making the playoffs are slipping daily, and Scherzer is in the final year of his contract. If they’re out of it in July, they should shop him. So what would he be worth at that point? It’s complicated. For multiple reasons. First, there's what we call the "October...

Recently, on an episode of MLB Tonight, John Smoltz was asked to compare the difference between signing Josh Donaldson or trading for [baseball-trade-values-player-link player="7589"]. His response was, to paraphrase: Donaldson doesn’t cost anything in prospects, but if Arenado was available? You’d have to “back up the truck.” In other words, he thinks trading for Arenado would cost a huge prospect haul. With all due respect to Smoltz, he is not a GM. He assumes...

Amidst all the noise about big-ticket free agent signings, a few trades happened at the recent Winter Meetings as well. Let’s break them down: Rangers trade [baseball-trade-values-player-link player="8839"] to the White Sox for [baseball-trade-values-player-link player="9693"] Despite the obvious overpay, we’re going to take partial credit for calling the light return on this one. Our model had Mazara’s value at zero -- which means we see no surplus value --...